Appropriate antibiotic use and their clinical evaluation through PK/PD analysis

Japanese Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 4, 2005, Pages 177-180

  Niki, Yoshihito ^a  

^a NONE

Author keywords

Adequate dosing; Appropriate antibiotic use; Clinical evaluation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; TELITHROMYCIN;

AREA UNDER THE CURVE; DRUG BLOOD LEVEL; DRUG USE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW;

EID: 24644465164     PISSN: 03881601     EISSN: None     Source Type: Journal    
DOI: 10.3999/jscpt.36.4_177     Document Type: Review

References (4)

1. Craig WA. Pharmacokinetic/pharmacodynamic parameters; nationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26(1): 1-10.
2. Tanigawara Y, Nomura H, Kagimoto N, Okumura K, Hori R. Population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases. Biol Pharm Bull 1995; 18: 315-20.
3. Ambrose PG, Bhavnani SM, Cirincione BB, Piedmonte M, Grasela TH. Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction. J Antimicrob Chemother 2003; 52(3): 435-40.